Stockreport

Hemispherian Initiates Phase 1/2a Clinical Trial of GLIX1 in Glioblastoma

BioLineRx Ltd. - American Depositary Shares  (BLRX) 
Last biolinerx ltd. - american depositary shares earnings: 5/14 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.biolinerx.com
PDF First-in-class TET2 activator targets DNA damage response in GBM and other cancersStrong preclinical efficacy, brain penetration, and safety profile support clinical adv [Read more]